145.33
-3.97 (-2.66%)
| Previous Close | 149.30 |
| Open | 148.89 |
| Volume | 206,650 |
| Avg. Volume (3M) | 211,305 |
| Market Cap | 5,226,153,984 |
| Price / Earnings (TTM) | 82.11 |
| Price / Sales | 5.36 |
| Price / Book | 6.79 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | 6.75% |
| Operating Margin (TTM) | 14.83% |
| Diluted EPS (TTM) | 1.77 |
| Quarterly Revenue Growth (YOY) | 12.50% |
| Quarterly Earnings Growth (YOY) | 31.60% |
| Total Debt/Equity (MRQ) | 63.16% |
| Current Ratio (MRQ) | 2.58 |
| Operating Cash Flow (TTM) | 158.51 M |
| Levered Free Cash Flow (TTM) | 138.84 M |
| Return on Assets (TTM) | 6.05% |
| Return on Equity (TTM) | 9.03% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (US) | Bullish | Bullish |
| Scientific & Technical Instruments (Global) | Bullish | Bullish | |
| Stock | Novanta Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 4.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -0.5 |
| Average | 2.13 |
|
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Growth |
| % Held by Insiders | 0.90% |
| % Held by Institutions | 102.82% |
| 52 Weeks Range | ||
| Median | 160.00 (10.09%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 03 Mar 2025 | 160.00 (10.09%) | Hold | 143.37 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 25 Feb 2025 | Announcement | Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024 |
| 28 Jan 2025 | Announcement | Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |